These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 24996045)

  • 21. Antibacterial activity after a single-dose of norfloxacin, ofloxacin and pipemidic acid detected in urine of volunteers.
    Cruciani M; Monzillo V; Navarra A; Tinelli C; Concia E
    Drugs Exp Clin Res; 1988; 14(8):533-7. PubMed ID: 3150350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of antibacterial activity of norfloxacin and ofloxacin in vitro by serum and experimental pleural exudates.
    Miglioli PA; Sartore P; Gianfranceschi L; Lanzafame P; Berti T
    J Chemother; 1989 Jul; 1(4 Suppl):140-1. PubMed ID: 16312342
    [No Abstract]   [Full Text] [Related]  

  • 23. Norfloxacin modulates the inflammatory response and directly affects neutrophils in patients with decompensated cirrhosis.
    Zapater P; Caño R; Llanos L; Ruiz-Alcaraz AJ; Pascual S; Barquero C; Moreu R; Bellot P; Horga JF; Muñoz C; Pérez J; García-Peñarrubia P; Pérez-Mateo M; Such J; Francés R
    Gastroenterology; 2009 Nov; 137(5):1669-79.e1. PubMed ID: 19660462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of pH, inoculum and media on the in vitro bactericidal activity of fosfomycin trometamol, norfloxacin and cotrimoxazole.
    Albini E; Belluco G; Marca G
    Chemioterapia; 1986 Aug; 5(4):268-72. PubMed ID: 3533286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The response of Escherichia coli to ciprofloxacin and norfloxacin.
    Elliott TS; Shelton A; Greenwood D
    J Med Microbiol; 1987 Feb; 23(1):83-8. PubMed ID: 3546699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates.
    Becnel Boyd L; Maynard MJ; Morgan-Linnell SK; Horton LB; Sucgang R; Hamill RJ; Jimenez JR; Versalovic J; Steffen D; Zechiedrich L
    Antimicrob Agents Chemother; 2009 Jan; 53(1):229-34. PubMed ID: 18838594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detection of endotoxins in the blood serum and ascitic fluid in liver cirrhosis].
    Malinowski S
    Wiad Lek; 1980 Jul; 33(14):1125-7. PubMed ID: 7001756
    [No Abstract]   [Full Text] [Related]  

  • 28. Interleukin-10-mediated heme oxygenase 1-induced underlying mechanism in inflammatory down-regulation by norfloxacin in cirrhosis.
    Gómez-Hurtado I; Zapater P; Bellot P; Pascual S; Pérez-Mateo M; Such J; Francés R
    Hepatology; 2011 Mar; 53(3):935-44. PubMed ID: 21374664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bacteriostatic effects of silver norfloxacin, silver sulfadiazine, and "moisture burn ointment"].
    Liao WZ
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1993 May; 9(3):184-5. PubMed ID: 8402351
    [No Abstract]   [Full Text] [Related]  

  • 30. [Susceptibility to norfloxacin of some bacterial strains causing urinary infections].
    Tuchiluş C; Poiată A; Bădicuţ I; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):383-6. PubMed ID: 16607805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymeric ocular drug delivery system for controlled release of norfloxacin. Part 1: In vitro characterization.
    Mukharya A; Jain SK; Dixit VK
    Pharmazie; 1994 Aug; 49(8):618-9. PubMed ID: 7938155
    [No Abstract]   [Full Text] [Related]  

  • 32. [Quinolone-resistant Escherichia coli in the health area of a 650-bed hospital].
    Fernández Fernández A; Lantero Benedito M; Gastañares Hernando MJ; Undabeitia Santisteban E; Fernández Santos F; Castaño Rodríguez A; Gil Fabra J; Martínez Castellanos F; Otero Mauricio G
    Actas Urol Esp; 1994 Jun; 18(6):634-8. PubMed ID: 7942213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Development of Escherichia coli strands resistant to quinolones in stools of patients with liver cirrhosis submitted to selective bowel decontamination].
    Aparicio JR; Such J; Gutiérrez A; Pérez-Mateo M; Plaza J; Arroyo A
    Med Clin (Barc); 1999 Sep; 113(7):241-5. PubMed ID: 10544377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma prekallikrein and endotoxemia in liver cirrhosis.
    van Vliet AC; van Vliet HH; Dzoljić-Danilović G; Wilson JH
    Thromb Haemost; 1981 Feb; 45(1):65-7. PubMed ID: 7018004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
    Ortiz J; Vila MC; Soriano G; Miñana J; Gana J; Mirelis B; Novella MT; Coll S; Sábat M; Andreu M; Prats G; Solá R; Guarner C
    Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Presence of enterotoxic and enteropathogenic strains of Escherichia coli and Klebsiella pneumoniae in dairy products. I. Production of thermostable enterotoxin (ST) and enteropathogenicity of the strains].
    Maciejska-Roczan K; Burzyńska H
    Rocz Panstw Zakl Hig; 1982; 33(3):185-91. PubMed ID: 6755632
    [No Abstract]   [Full Text] [Related]  

  • 37. Resistance of Klebsiella pneumoniae strains producing and not producing ESBL (extended-spectrum beta-lactamase) type enzymes to selected non-beta-lactam antibiotics.
    Sekowska A; Janicka G; Kłyszejko C; Wojda M; Wróblewski M; Szymankiewicz M
    Med Sci Monit; 2002 Mar; 8(3):BR100-4. PubMed ID: 11889457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of endotoxins and other pyrogens using human whole blood.
    Fennrich S; Fischer M; Hartung T; Lexa P; Montag-Lessing T; Sonntag HG; Weigandt M; Wendel A
    Dev Biol Stand; 1999; 101():131-9. PubMed ID: 10566786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urine bactericidal activity against resistant Escherichia coli in an in vitro pharmacodynamic model simulating urine concentrations obtained after 2000/125 mg sustained-release co-amoxiclav and 400 mg norfloxacin administration.
    Alou L; Aguilar L; Sevillano D; Giménez MJ; Cafini F; Valero E; Relaño MT; Prieto J
    J Antimicrob Chemother; 2006 Apr; 57(4):714-9. PubMed ID: 16492718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of pH and human urine on the antibacterial activity of ciprofloxacin, norfloxacin and ofloxacin.
    Zeiler HJ
    Drugs Exp Clin Res; 1985; 11(5):335-8. PubMed ID: 2941261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.